搜索
Search

Policies & Regulations

Recommended News

Sichuan

Sichuan Provincial Pharmaceutical Enterprises Import And Export Alliance Held Its Second Sponsor Meeting
2020-05-22

In order to further implement the guiding spirit of the Provincial Party Committee and the Provincial Government on strengthening and regulating the export of epidemic prevention materials, and to promote the effective development of the Sichuan Pharmaceutical Enterprise Import and Export Alliance, the Sichuan Pharmaceutical Enterprise Import and Export Alliance held its second session on the afternoon of May 21, 2020. Sponsor meetings.
Group

Group to go to sea Sichuan sets up a pharmaceutical enterprise import and export alliance
2020-04-03

On the morning of April 3, the inaugural meeting of the Sichuan Pharmaceutical Enterprises Import and Export Alliance was held in Chengdu. Sichuan Foreign Trade Group, Sichuan Kelun Pharmaceutical, Xinjinshifeng Medical, Mike Biology, Laoken Medical, Tiantian Medical, and Sichuan Branch of the Export-Import Bank of China, as the promoters, jointly signed the alliance agreement, marking the "Sichuan Province The "Import and Export Alliance of Pharmaceutical Enterprises" was formally established.
The

The Sichuan Pharmaceutical Enterprises Import and Export Alliance was formally established
2020-04-03

On the morning of April 3, the inaugural meeting of the Sichuan Pharmaceutical Enterprises Import and Export Alliance was successfully held in Chengdu Jinjiang Hotel. Sichuan Foreign Trade Group, Sichuan Kelun Pharmaceutical, Xinjinshifeng Medical, Mike Biology, Laoken Medical, Tiantian Medical, Sichuan Branch of the Export-Import Bank of China, as the initiators, signed the alliance agreement together, marking the "Sichuan Province "Pharmaceutical Enterprise Import and Export Alliance" was formally established, and representatives of key alliance member companies attended the meeting.
The

The Sichuan Pharmaceutical Enterprises Import and Export Alliance held a communication and coordination meeting
2020-03-27

On March 26, the Sichuan Pharmaceutical Enterprises Import and Export Union held a preparatory work meeting. The principals of the seven alliance sponsor units including Sichuan Foreign Trade Group, Sichuan Kelun Pharmaceutical, and Chengdu Xinjinshifeng attended the meeting.
Reform

Reform raw material management and encourage technological innovation-the "Regulations" escort the innovation and development of the industry
2020-06-30

The "Regulations on the Supervision and Administration of Cosmetics" (hereinafter referred to as the "Regulations"), which has attracted much attention from the industry, is finally released! Compared with the "Regulations on Cosmetics Hygiene Supervision" promulgated in 1989, the contents of the "Regulations" have many new changes. Among them, the classification and management of new raw materials and the encouragement of technological innovation are undoubtedly a highlight of the "Regulations".
The

The heads of the Ministry of Justice, the State Administration of Market Supervision, and the Food and Drug Administration answer reporters’ questions on the Regulations on Supervision and Administration of Cosmetics
2020-06-29

On June 16, 2020, Premier Li Keqiang signed the State Council Order No. 727, promulgating the "Regulations on Supervision and Administration of Cosmetics" (hereinafter referred to as the "Regulations"). The "Regulations" shall come into force on January 1, 2021. A few days ago, the heads of the Ministry of Justice, the State Administration of Market Supervision, and the Food and Drug Administration answered questions from reporters on related issues in the Regulations.
Notice

Notice of the Comprehensive Department of the State Food and Drug Administration on matters concerning the registration of licensed pharmacists in deeply impoverished areas such as "three regions and three states"
2020-06-24

In accordance with the "Notice of the General Office of the Ministry of Human Resources and Social Security on Matters Concerning the Separate Delineation of Vocational Qualification Examination Standards for Nurses in Deeply Poverty Areas such as the "Three Districts and Three States" (for Trial Implementation)" (Human She Ding Fa [2019] No. 77) It is required that those who have registered for the vocational qualification examination for licensed pharmacists in the corresponding cities, districts, and states in the "three districts and three states" and other deeply impoverished areas have not met the national qualification standards, but within the prescribed period of validity of the examination results, all subjects have reached the city, District and state qualified standards, you can apply for a valid local professional qualification certificate. In order to standardize the registration and approval of the professional qualifications of licensed pharmacists in deeply impoverished areas such as the "three districts and three states", and to further strengthen the construction of the team of licensed pharmacists in deeply impoverished areas such as the "three districts and three states", the relevant matters are hereby notified as follows:
Notice

Notice of the Sichuan Provincial Drug Administration on Launching Special Rectification Actions for Drug Online Sales Violations
2020-06-01

In order to further standardize drug online sales activities, severely crack down on illegal drug online sales, and effectively guarantee the safety of public medication, according to the "Notice on Launching Special Rectification Actions for Drugs Online Sales" (Drug Administration Comprehensive Drug Guan (2020) No. 35) requires that from now to October this year, special rectification of illegal drug online sales will be carried out across the province. The relevant matters are hereby notified as follows:
2020

2020 Medical Device "Clear Network" Action Work Plan
2020-05-29

In order to strengthen the supervision of online medical device sales, thoroughly implement the "four strictest" requirements for drug safety, fully implement the "Measures for the Supervision and Administration of Medical Device Online Sales" and "Administrative Measures for Internet Drug Information Services", and further strengthen medical device online transaction services The management responsibility of the third-party platform (hereinafter referred to as the third-party platform) and the main responsibility of the medical device online sales enterprise (hereinafter referred to as the online sales enterprise), regulate the order of medical device online marketing, severely punish all kinds of violations of laws and regulations, and ensure the safety of the masses in the use of equipment. To save the actual situation, formulate this plan.
Notice

Notice of the Comprehensive Department of the State Drug Administration on Doing a Good Job in the Supervision and Administration of Drug Exports During the Period of Epidemic Prevention and Control
2020-04-03

The Drug Administration of all provinces, autonomous regions, and municipalities directly under the Central Government, and the Drug Administration of Xinjiang Production and Construction Corps:
The

The General Administration of Market Supervision announced the "Measures for the Administration of Drug Registration" and "Measures for the Supervision and Administration of Drug Production"
2020-03-30

On March 30, the State Administration for Market Regulation announced the "Administrative Measures for Drug Registration" by Order No. 27 of the General Administration and the "Administrative Measures for the Supervision and Administration of Drug Production" by Order 28. The two regulations will be officially implemented on July 1, 2020.
The

The State Food and Drug Administration issued 5 standards including the "Basic Data Set for Drug Marketing Authorization Holders and Manufacturers"
2020-03-11

On March 6, 2020, the National Food and Drug Administration issued the "Basic Traceability Data Set for Drug Marketing Authorization Holders and Manufacturers", "The Traceability Basic Data Set for Drug Dealers", "The Traceability Basic Data Set for Drug Use Units", and "Drug Traceability to Consumers" Inquire about 5 standards including Basic Data Set, Basic Technical Requirements for Drug Traceability Data Exchange. In addition to the previously issued "Guidelines for the Construction of Drug Information Traceability System", "Drug Traceability Code Coding Requirements", "Basic Technical Requirements for Drug Traceability Systems", "Vaccine Traceability Basic Data Set", and "Vaccine Traceability Data Exchange Basic Technical Requirements", etc. Standards. So far, the 10 drug traceability standards compiled by the State Drug Administration have all been released and implemented.
Notice

Notice of the Comprehensive Department of the State Food and Drug Administration on Carrying out the Special Inspection Work of Nationally Organized Drug Centralized Procurement and Use
2020-03-10

In order to further implement the decision and deployment of the Party Central Committee and the State Council on the state-organized centralized procurement and use of drugs, strengthen the quality supervision of the centralized procurement and use of selected drugs, and effectively ensure the safety of the people's medication. The State Food and Drug Administration has decided to conduct special inspections on selected drugs for the centralized procurement and use of drugs organized by the state. The relevant matters are hereby notified as follows:
Current Position:
Homepage
/
/
/
2020 Medical Device "Clear Network" Action Work Plan

2020 Medical Device "Clear Network" Action Work Plan

2020 Medical Device "Clear Network" Action Work Plan

In order to strengthen the supervision of online sales of medical devices, thoroughly implement the "four strictest" requirements for drug safety, fully implement the "Measures for the Supervision and Administration of Medical Device Online Sales" and "Administrative Measures for Internet Drug Information Services", and further strengthen medical device online transaction services The management responsibility of the third-party platform (hereinafter referred to as the third-party platform) and the main responsibility of the medical device online sales enterprise (hereinafter referred to as the online sales enterprise), regulate the online marketing order of medical devices, severely punish all kinds of violations of laws and regulations, and ensure the safety of the masses in the use of equipment. To save the actual situation, formulate this plan.

1. Guiding ideology and work objectives

(1) Guiding ideology

Guided by Xi Jinping’s thoughts on socialism with Chinese characteristics for a new era, implement the central government’s "four strictest" requirements for drug safety, adhere to the principles of "online" and "offline" linkage, information and product integration, and effectively strengthen the online sales of medical devices Supervise and manage, severely crack down on illegal and illegal behaviors in the online and offline sales of medical devices, continue to purify the online sales environment of medical devices, and ensure the safety of the public in using devices.

(two) work objectives

1. Strengthen the implementation of third-party platform management responsibilities

The third-party platform fully implements the management responsibilities of settled enterprises, such as verification and registration, quality and safety monitoring, product quality and safety hidden danger information release, suppression of illegal online sales, suspension of platform services for serious violations, and related reports.

2. Strengthen the implementation of the main responsibility of medical device online sales enterprises

Online sales companies ensure that the information is true, accurate, complete, and traceable, and that transactions comply with legal requirements.

3. Strengthen the implementation of the territorial supervision responsibility of the drug supervision department

The relevant departments (units) of the Provincial Bureau and the supervisory departments of each city (prefecture) shall comprehensively strengthen the supervision of third-party platforms and online sales companies in the administrative area in accordance with their duties, and supervise the implementation of management responsibilities of third-party platforms and the implementation of main responsibilities of online sales companies. Strictly investigate and deal with violations of laws and regulations.

4. Strengthen the monitoring of online transactions of medical devices and the handling of clues.

The relevant departments (units) of the provincial bureau promptly push the relevant clues of online sales enterprises on the national medical device online transaction monitoring platform to the municipal (prefecture) regulatory authorities, and each city (prefecture) regulatory agency shall promptly report and investigate on the national medical device online transaction monitoring platform And disposal.

5. Strengthen the investigation and punishment of violations of laws and regulations

All relevant departments (units) of the Provincial Bureau and the supervisory departments of each city (state) shall, in accordance with the "four strictest" requirements, promptly investigate and deal with various violations of laws and regulations in accordance with the law, and further enhance the authority and deterrence of law enforcement.

2. Key tasks

(1) Check the full performance of management responsibilities by third-party platforms

All relevant departments (units) of the Provincial Bureau strengthen the supervision and inspection of third-party platforms in the administrative area, and focus on checking the performance of the following management responsibilities by third-party platforms.

1. Whether the third-party platform fulfills various statutory obligations in accordance with the Measures for the Supervision and Administration of Online Sales of Medical Devices;

2. After the third-party platform monitors and discovers the illegal behavior of the settled company, whether it reports to the local drug regulatory authority in a timely manner;

3. Whether the third-party platform cooperates with the drug regulatory authority to perform relevant investigation and verification obligations;

4. Whether the third-party platform promptly disposes of the illegally settled enterprises and product information in accordance with the requirements of the regulatory authorities.

(2) Check the full performance of the main responsibility of online sales companies

The municipal (prefecture) supervisory department strengthens the supervision and inspection of network sales enterprises in the administrative area, and focuses on the inspection of the performance of the following main responsibilities of the network sales enterprises.

1. Whether the information released by online sales companies through the Internet is true, accurate, complete, and traceable, and whether there are false and exaggerated publicity;

2. Whether the products and business behaviors sold by online sales companies meet the relevant requirements of the "Regulations on the Supervision and Administration of Medical Devices", "Measures for the Supervision and Administration of Medical Device Operation", "Measures for the Supervision and Administration of Online Medical Device Sales", and "Administrative Measures on Internet Drug Information Services".

(3) Strengthen the investigation and punishment of violations of laws and regulations by regulatory agencies at all levels

The relevant departments (units) of the provincial bureau and the supervisory departments of each city (prefecture) shall promptly investigate and deal with the illegal clues found in network monitoring, public opinion monitoring, complaints and reporting, and focus on the investigation and punishment of third-party platforms and online sales companies. Irregularities.

1. The third-party platform failed to fulfill its statutory obligations, failed to verify the settled company, failed to monitor the medical device sales behavior and information on the platform, and found illegal activities and failed to stop online transaction services and reporting illegal activities;

2. Internet sales companies sell unregistered or filed medical device products, publish false medical device product information and other violations of laws and regulations;

3. Third-party platforms and online sales companies do not cooperate with the supervision and inspection of the drug regulatory department, and refuse, conceal, or provide untruthful information and other illegal activities.

(4) Strengthen the monitoring of online medical device transactions

The National Medical Device Network Transaction Monitoring Platform has carried out comprehensive monitoring of third-party platforms and online sales companies across the country, and opened up the medical device network monitoring function. The relevant departments (units) of the provincial bureau and the municipal (prefecture) regulatory authorities have made full use of the platform to carry out Medical device online transaction monitoring.

1. All relevant departments (units) of the provincial bureau make full use of the national medical device network transaction monitoring platform to timely transfer the national medical device network transaction monitoring platform and other relevant clues of online sales enterprises discovered by other provincial bureaus to the municipal (prefecture) regulatory authorities. COVID-19 prevention and control related new coronavirus detection reagents, ventilators, medical protective clothing, medical masks, infrared thermometers, five types of medical equipment and contact lenses, blood glucose meters, condoms, therapeutic instruments, dental root canal nails, dental resin and other medical equipment are For key products, conduct comprehensive monitoring and clue handling on third-party platforms in the province.

2. Each city (prefecture) regulatory authority shall conduct comprehensive monitoring and clue handling of online sales companies within its jurisdiction, attach great importance to the problems reflected in information monitoring, and conduct investigations and verifications in the first time on the problems reflected in the information transmitted by the national and provincial bureaus Dispose of them in accordance with the law, and upload the disposal situation to the national medical device network transaction monitoring platform in a timely manner.

(5) Strengthen departmental collaboration and execution connection

The relevant departments (units) of the Provincial Bureau and the supervisory departments of each city (state) should strengthen inter-departmental coordinated supervision and jointly crack down on illegal activities of medical device online sales. For matters involving website closure or blocking, the network information and communications management departments shall be notified in a timely manner. For enterprises that cannot be contacted, they must promptly notify the market supervision department to be included in the abnormal list. Those suspected of crimes shall be transferred to the public security organs in a timely manner to jointly crack down on violations of laws and regulations.

Three, job requirements

(1) Improve political positions

The relevant departments (units) of the provincial bureau and the supervisory departments of each city (prefecture) should attach great importance to the "net cleaning" action, carefully formulate work plans, take effective measures, and effectively strengthen the supervision and inspection of third-party platforms and online sales companies in their administrative regions , Seriously investigate and deal with illegal acts.

(2) Strengthen demonstration and guidance

According to the requirements of the State Food and Drug Administration, Sichuan Province will select a number of cities from among the 21 municipal (prefecture) regulatory agencies to serve as contact points for regulatory work. All municipal (prefecture) regulatory agencies should focus on the construction of typical demonstrations and give full play to the leading role of demonstration units.

(3) Strengthen assessment and evaluation

The provincial bureau will timely supervise and inspect the implementation of the "cleaning network" action in each city (state), and include the implementation of local regulatory responsibilities, the disposal of network monitoring clues, and the investigation and punishment of violations of laws and regulations into the content of the year-end assessment.

(4) Strictly investigate violations

All municipal (prefecture) supervisory departments must conscientiously implement the "four most stringent" requirements, and intensify inspections of violations of laws and regulations. "Online" false information must not be "deleted" or "taken off the shelf". It is necessary to dig in and investigate thoroughly, and never tolerate it.

Each city (prefecture) supervisory authority shall summarize and analyze the work of the medical device "cleaning network" in 2020, sort out existing problems and put forward work recommendations, collect and sort out typical cases, and fill in the medical device "cleaning network" operation supervision and inspection form ( Attachment 1), Network Monitoring and Disposal Status Sheet (Annex 2), and submit work summary, action supervision and inspection status, network monitoring and disposal status and collected typical cases to the Provincial Bureau of Medical Device Supervision before November 15, 2020 Place. If there are major issues in the work, they must be reported in time.

Contact: Chen Sijia Tel: 028-86785825

Address: Medical Device Supervision and Administration Office, No. 98 Yusha Road, Qingyang District, Chengdu

Email: 1394725515@qq.com

Attachment:

1. Supervision and inspection status table of the medical device "cleaning network" action

2. Network monitoring and disposal status table

3. Typical case format template

Sichuan Drug Administration (2020) No. 71 (Annex)

COPYRIGHT © 2020  Sichuan Pharmaceutical Enterprises Import And Export Alliance  All rights reserved

ADD:No. 168, Jianghan Road, Qingyang District, Chengdu City, Sichuan Province     TEL:028-86283398     Email:IEASPE@163.com     Website:www.IEASPE.com

Powered by www.300.cn     蜀ICP备19031506号-2

028-86283398
IEASPE@163.com